# Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

> **NCT01270984** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 30 (actual)

## Conditions studied

- Chronic Myeloid Leukemia
- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Luckyvec 400mg film coated tablet
- **DRUG:** Glivec 100mg film coated tablet

## Key facts

- **NCT ID:** NCT01270984
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270984, "Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01270984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*